Ke-Wei Chen
Papers
1
Total Citations
3
H-Index
1
About
Ke-Wei Chen is a prominent urologic oncologist whose research focuses on the surgical management of renal cell carcinoma (RCC), particularly in complex cases involving venous tumor thrombus (VTT). His major contributions center on elucidating the risk factors for renal insufficiency following radical nephrectomy with thrombectomy, a high-stakes procedure that balances oncologic control with renal preservation. Through a rigorous systematic review, Chen synthesized global evidence to identify key predictors of postoperative kidney function decline, providing critical guidance for surgical decision-making and patient counseling. His work highlights the delicate interplay between aggressive tumor resection and long-term renal outcomes, directly impacting clinical protocols for advanced RCC. While his most-cited paper to date has garnered 3 citations, its recent publication in 2025 signals emerging influence in the field. Chen’s research is particularly valuable for urologic surgeons and oncologists navigating the challenges of managing RCC with VTT, offering evidence-based insights that improve both survival and quality of life. His dedication to systematic evidence synthesis underscores a commitment to advancing precision in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1